z-logo
open-access-imgOpen Access
Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis
Author(s) -
Kimitoshi Kimura,
Hirohiko Hohjoh,
Masashi Fukuoka,
Wakiro Sato,
Shinji Oki,
Chiharu Tomi,
Hiromi Yamaguchi,
Takayuki Kondo,
Ryōsuke Takahashi,
Takashi Yamamura
Publication year - 2017
Publication title -
nature communications
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.559
H-Index - 365
ISSN - 2041-1723
DOI - 10.1038/s41467-017-02406-2
Subject(s) - foxp3 , multiple sclerosis , microvesicles , receptor , transforming growth factor beta , pathogenesis , insulin like growth factor 1 receptor , immunology , transforming growth factor , growth factor , biology , microbiology and biotechnology , cancer research , medicine , microrna , immune system , gene , genetics
Multiple sclerosis (MS) is a T cell-mediated autoimmune disease of the central nervous system. Foxp3 + regulatory T (Treg) cells are reduced in frequency and dysfunctional in patients with MS, but the underlying mechanisms of this deficiency are unclear. Here, we show that induction of human IFN-γ − IL-17A − Foxp3 + CD4 + T cells is inhibited in the presence of circulating exosomes from patients with MS. The exosomal miRNA profile of patients with MS differs from that of healthy controls, and let-7i , which is markedly increased in patients with MS, suppresses induction of Treg cells by targeting insulin like growth factor 1 receptor ( IGF1R ) and transforming growth factor beta receptor 1 ( TGFBR1 ). Consistently, the expression of IGF1R and TGFBR1 on circulating naive CD4 + T cells is reduced in patients with MS. Thus, our study shows that exosomal let-7i regulates MS pathogenesis by blocking the IGF1R/TGFBR1 pathway.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom